Bio Nano Consulting completes public funding phase

BNC opens new London offices as part of expansion plan

15-Nov-2010 - United Kingdom

Bio Nano Consulting (BNC announced the completion of its publicly funded phase of corporate development. At the same time, to mark the company’s transition to a self-supporting and revenue-funded organisation, BNC has unveiled new expanded London offices, acquired to meet the increasing demand for its services and specialist expertise.

BNC was formed in 2007 as the UK’s Micro and Nanotechnology Centre focused on bionanotechnology, with funding from the Technology Strategy Board (TSB) and the London Development Agency (LDA). The funding provided open access to facilities in BNC’s partner institutions, which is to continue.

Since the company’s launch, Bio Nano Consulting has completed 22 projects for 16 life science and high-technology sector companies. Furthermore, the company already has a further 10 projects actively in progress. BNC is now partnered with three leading academic institutions, namely Imperial College London, University College London and the School of Pharmacy, University of London. The formation of a fourth, internationally focused partnership is expected to be announced this year.

The company’s new London office premises are located in Central London.

Commenting on BNC’s new status as a fully self financed and revenues supporting organisation, CEO, Dr David Sarphie, commented: “We are pleased to have completed the first phase of our business plan and to have exceeded our growth projections. We have made effective use of TSB and LDA publicly funded resources to help UK and international clients adopt nanotechnology and also to drive the success of Bio Nano Consulting, enabling the company to emerge as a fully self-financed, revenue-driven enterprise. We predict continued revenue growth as we confidently embark on the planned second phase in our company’s development.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances